YAN Heng, YE Qingyi, HAO Fei, HUANG Dongping, MAI Yue, ZHONG Baiyu. In Vitro Study on Th1/Th2 Shift Modulated by CTLA4Ig in Psoriasis[J].Chinese Journal of Dermatology, 2002, 35(2): 114-116.
[1] Abbas AK, Murphy KM, Sher A.Functional diversity of helper T lymphocytes.Nature, 1996, 383(6603):787-793. [2] Judge TA, Tang A, Spain LM, et al.The in vivo mechanism of action of CTLA4Ig.J Immunol, 1996, 156:2294-2299. [3] 张峻岭,陈学荣,殷金珠.银屑病患者淋巴细胞对葡萄球菌和链球菌超抗原刺激的增殖反应.中华皮肤科杂志,1999, 32:126. [4] Austin LM, Ozawa M, Kikuchi T, et al.The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations:a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients.J Invest Dermatol, 1999, 113:752-759. [5] Finck BK, Linsley PS, Wofsy D.Treatment of murine lupus with CTLA4Ig.Science, 1994, 265(5176):1225-1227.